What are the major opportunities in the Kidney Fibrosis Treatment market? What are the strategies for the Kidney Fibrosis Treatment market?

For detailed insights on the major opportunities and strategies in the Kidney Fibrosis Treatment market, Read More

How does the Kidney Fibrosis Treatment market relate to the overall economy and other similar markets?

For detailed insights on Kidney Fibrosis Treatment's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Kidney Fibrosis Treatment market growth? SWOT analysis of the Kidney Fibrosis Treatment market.

For detailed insights on the key dynamics influencing the Kidney Fibrosis Treatment market growth and SWOT analysis of the Kidney Fibrosis Treatment industry, Read More

Kidney Fibrosis Treatment Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Kidney Fibrosis Treatment Market Report 2026

Name: Kidney Fibrosis Treatment Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Treatment Type (Angiotensin-Converting Enzyme (Ace) Inhibitors, Angiotensin Ii Receptor Blockers (Arbs), Pirfenidone, Renin Inhibitors, Vasopeptidase Inhibitors, Other Treatment Types), By Diagnosis (Blood Tests, Urine Tests, Imaging Tests), By Application (Chronic Kidney Diseases, Kidney Cancer Treatment, Other Applications), By End-User (Clinics, Research Center, Hospitals) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Kidney Fibrosis Treatment Market Overview

• Kidney Fibrosis Treatment market size has reached to $6.06 billion in 2025

• Expected to grow to $8.84 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%

• Growth Driver: Rising Prevalence Of chronic kidney disease Driving Growth In The Market Due To Increasing Rates Of Diabetes And Hypertension

• Market Trend: Targeted Ileal-Release Immunomodulatory Therapies Drive Treatment Advancements

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Kidney Fibrosis Treatment Market?

Kidney fibrosis treatment refers to therapeutic strategies aimed at slowing, halting, or reversing the progression of fibrosis in the kidneys. Kidney fibrosis is the excessive accumulation of extracellular matrix proteins such as collagen, resulting to scarring and functional decline of kidney tissue, commonly associated with chronic kidney disease (CKD).

The main treatment types of kidney fibrosis treatment are angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), pirfenidone, renin inhibitors, vasopeptidase inhibitors, and others. Angiotensin-converting enzyme (ACE) inhibitors help lower blood pressure and reduce heart strain by blocking the enzyme that converts angiotensin I into angiotensin II. Diagnosis involves blood and urine tests, imaging scans, and kidney biopsies. The treatments are applied in cases of chronic kidney diseases, kidney cancer, and other conditions. These are used by various end-users such as clinics, research centers, and hospitals.

Kidney Fibrosis Treatment Market Global Report 2026 Market Report bar graph

What Is The Kidney Fibrosis Treatment Market Size and Share 2026?

The kidney fibrosis treatment market size has grown strongly in recent years. It will grow from $6.06 billion in 2025 to $6.54 billion in 2026 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to rising prevalence of chronic kidney disease, limited effectiveness of conventional therapies, increased use of ace inhibitors and arbs, growing healthcare burden of renal failure, expansion of nephrology care services.

What Is The Kidney Fibrosis Treatment Market Growth Forecast?

The kidney fibrosis treatment market size is expected to see strong growth in the next few years. It will grow to $8.84 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to advancements in targeted antifibrotic agents, increasing aging population with ckd, growing adoption of precision medicine in nephrology, rising investment in renal research, improved early-stage kidney disease diagnosis. Major trends in the forecast period include increasing focus on antifibrotic drug development, growing use of combination therapies for ckd, rising research in stem cell and regenerative therapies, expansion of early diagnostic and monitoring tools, increasing clinical trials targeting renal fibrosis pathways.

Book your 30 minutes free consultation with our research experts

Global Kidney Fibrosis Treatment Market Segmentation

1) By Treatment Type: Angiotensin-Converting Enzyme (Ace) Inhibitors, Angiotensin Ii Receptor Blockers (Arbs), Pirfenidone, Renin Inhibitors, Vasopeptidase Inhibitors, Other Treatment Types

2) By Diagnosis: Blood Tests, Urine Tests, Imaging Tests

3) By Application: Chronic Kidney Diseases, Kidney Cancer Treatment, Other Applications

4) By End-User: Clinics, Research Center, Hospitals

Subsegments:

1) By Angiotensin-Converting Enzyme (Ace) Inhibitors: Enalapril, Captopri, Lisinopril, Ramipril

2) By Angiotensin Ii Receptor Blockers (Arbs): Losartan, Telmisartan, Valsartan, Irbesartan

3) By Pirfenidone: Branded Pirfenidone, Generic Pirfenidone

4) By Renin Inhibitors: Aliskiren, Experimental Renin Inhibitors

5) By Vasopeptidase Inhibitors: Omapatrilat, Sampatrilat

6) By Other Treatment Types: Anti-Inflammatory Agents, Stem Cell Therapy, Antifibrotic Agents Under Clinical Trials, Gene Therapy

What Is The Driver Of The Kidney Fibrosis Treatment Market?

The increasing prevalence of chronic kidney diseases is expected to propel the growth of the kidney fibrosis treatment market going forward. Chronic kidney disease (CKD) is a gradual loss of kidney function over time, often due to conditions such as diabetes or hypertension, resulting to the accumulation of waste products in the body. The increasing prevalence of chronic kidney disease (CKD) is largely driven by the rising rates of diabetes, which damages kidney blood vessels and impairs their filtering ability. Kidney fibrosis treatment helps chronic kidney disease (CKD) patients by targeting the scarring of kidney tissue, reducing inflammation, and slowing the progression of kidney damage, ultimately preserving kidney function. For instance, in July 2025, according to Hamadan University of Medical Sciences, a Iran-based university, the global number of newly diagnosed chronic kidney diseases is projected to rise to 25.06 million by 2030. Therefore, the increasing prevalence of chronic kidney diseases is driving growth of the kidney fibrosis treatment industry.

Key Players In The Global Kidney Fibrosis Treatment Market

Major companies operating in the kidney fibrosis treatment market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, AstraZeneca PLC, Gilead Sciences Inc., Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Chinook Therapeutics Inc., Akebia Therapeutics Inc., Travere Therapeutics Inc., Reata Pharmaceuticals Inc., ProKidney LLC, Tvardi Therapeutics Inc., Alentis Therapeutics AG, Galecto Biotech AB, Vertex Pharmaceuticals Incorporated, Insilico Medicine Inc., Purespring Therapeutics Inc., La Jolla Pharmaceutical Company, Cara Therapeutics Inc

Global Kidney Fibrosis Treatment Market Trends and Insights

Major companies operating in the kidney fibrosis treatment market are focusing on targeted ileal-release immunomodulatory therapies, such as NEFECON, an oral delayed-release budesonide capsule that delivers the drug specifically to the distal ileum to modulate gut-associated B-cells and reduce pathogenic IgA production, slowing kidney fibrosis progression in IgA nephropathy patients. For instance, in June 2024, Everest Medicines, a China-based biopharmaceutical company, launched NEFECON. The therapy features an enteric-coated, delayed-release formulation to minimize systemic steroid exposure, targets mucosal B-cells in the gut to address the root cause of IgA nephropathy, and has demonstrated the ability to significantly reduce kidney function decline.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Kidney Fibrosis Treatment Market?

In April 2025, Novartis, a Switzerland-based pharmaceutical company developing a broad pipeline in renal and rare-disease therapies, acquired Regulus Therapeutics for an undisclosed amount. With this acquisition, Novartis aimed to bolster its kidney-disease franchise by gaining Regulus’s lead RNA-therapeutic candidate, farabursen, a microRNA-17 inhibitor for autosomal dominant polycystic kidney disease (ADPKD), thereby strengthening its pipeline in renal therapies. Regulus Therapeutics is a US-based (San Diego) biopharmaceutical company focused on developing first-in-class microRNA therapeutics, including farabursen for ADPKD.

Regional Insights

North America was the largest region in the kidney fibrosis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Kidney Fibrosis Treatment Market?

The kidney fibrosis treatment market includes revenues earned by entities by providing services such as pharmacological treatment, diagnostic and monitoring services, and lifestyle and nutritional support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Kidney Fibrosis Treatment Market Report 2026?

The kidney fibrosis treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the kidney fibrosis treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Kidney Fibrosis Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$6.54 billion
Revenue Forecast In 2035	$8.84 billion
Growth Rate	CAGR of 8.0% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Treatment Type, Diagnosis, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, AstraZeneca PLC, Gilead Sciences Inc., Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Chinook Therapeutics Inc., Akebia Therapeutics Inc., Travere Therapeutics Inc., Reata Pharmaceuticals
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Kidney Fibrosis Treatment Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Kidney Fibrosis Treatment Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Kidney Fibrosis Treatment Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Kidney Fibrosis Treatment Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Focus On Antifibrotic Drug Development

4.2.2 Growing Use Of Combination Therapies For Ckd

4.2.3 Rising Research In Stem Cell And Regenerative Therapies

4.2.4 Expansion Of Early Diagnostic And Monitoring Tools

4.2.5 Increasing Clinical Trials Targeting Renal Fibrosis Pathways

5. Kidney Fibrosis Treatment Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Nephrology Clinics

5.3 Research Centers

5.4 Dialysis Centers

5.5 Specialty Renal Care Clinics

6. Kidney Fibrosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Kidney Fibrosis Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Kidney Fibrosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Kidney Fibrosis Treatment Market Size, Comparisons And Growth Rate Analysis

7.3. Global Kidney Fibrosis Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Kidney Fibrosis Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Kidney Fibrosis Treatment Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Kidney Fibrosis Treatment Market Segmentation

9.1. Global Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Angiotensin-Converting Enzyme (Ace) Inhibitors, Angiotensin Ii Receptor Blockers (Arbs), Pirfenidone, Renin Inhibitors, Vasopeptidase Inhibitors, Other Treatment Types

9.2. Global Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Blood Tests, Urine Tests, Imaging Tests

9.3. Global Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chronic Kidney Diseases, Kidney Cancer Treatment, Other Applications

9.4. Global Kidney Fibrosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinics, Research Center, Hospitals

9.5. Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Angiotensin-Converting Enzyme (Ace) Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Enalapril, Captopri, Lisinopril, Ramipril

9.6. Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Angiotensin Ii Receptor Blockers (Arbs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Losartan, Telmisartan, Valsartan, Irbesartan

9.7. Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Pirfenidone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Branded Pirfenidone, Generic Pirfenidone

9.8. Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Renin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Aliskiren, Experimental Renin Inhibitors

9.9. Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Vasopeptidase Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Omapatrilat, Sampatrilat

9.10. Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anti-Inflammatory Agents, Stem Cell Therapy, Antifibrotic Agents Under Clinical Trials, Gene Therapy

10. Kidney Fibrosis Treatment Market Regional And Country Analysis

10.1. Global Kidney Fibrosis Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Kidney Fibrosis Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Kidney Fibrosis Treatment Market

11.1. Asia-Pacific Kidney Fibrosis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Kidney Fibrosis Treatment Market

12.1. China Kidney Fibrosis Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Kidney Fibrosis Treatment Market

13.1. India Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Kidney Fibrosis Treatment Market

14.1. Japan Kidney Fibrosis Treatment Market Overview

14.2. Japan Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Kidney Fibrosis Treatment Market

15.1. Australia Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Kidney Fibrosis Treatment Market

16.1. Indonesia Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Kidney Fibrosis Treatment Market

17.1. South Korea Kidney Fibrosis Treatment Market Overview

17.2. South Korea Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Kidney Fibrosis Treatment Market

18.1. Taiwan Kidney Fibrosis Treatment Market Overview

18.2. Taiwan Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Kidney Fibrosis Treatment Market

19.1. South East Asia Kidney Fibrosis Treatment Market Overview

19.2. South East Asia Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Kidney Fibrosis Treatment Market

20.1. Western Europe Kidney Fibrosis Treatment Market Overview

20.2. Western Europe Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Kidney Fibrosis Treatment Market

21.1. UK Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Kidney Fibrosis Treatment Market

22.1. Germany Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Kidney Fibrosis Treatment Market

23.1. France Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Kidney Fibrosis Treatment Market

24.1. Italy Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Kidney Fibrosis Treatment Market

25.1. Spain Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Kidney Fibrosis Treatment Market

26.1. Eastern Europe Kidney Fibrosis Treatment Market Overview

26.2. Eastern Europe Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Kidney Fibrosis Treatment Market

27.1. Russia Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Kidney Fibrosis Treatment Market

28.1. North America Kidney Fibrosis Treatment Market Overview

28.2. North America Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Kidney Fibrosis Treatment Market

29.1. USA Kidney Fibrosis Treatment Market Overview

29.2. USA Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Kidney Fibrosis Treatment Market

30.1. Canada Kidney Fibrosis Treatment Market Overview

30.2. Canada Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Kidney Fibrosis Treatment Market

31.1. South America Kidney Fibrosis Treatment Market Overview

31.2. South America Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Kidney Fibrosis Treatment Market

32.1. Brazil Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Kidney Fibrosis Treatment Market

33.1. Middle East Kidney Fibrosis Treatment Market Overview

33.2. Middle East Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Kidney Fibrosis Treatment Market

34.1. Africa Kidney Fibrosis Treatment Market Overview

34.2. Africa Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Kidney Fibrosis Treatment Market Regulatory and Investment Landscape

36. Kidney Fibrosis Treatment Market Competitive Landscape And Company Profiles

36.1. Kidney Fibrosis Treatment Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Kidney Fibrosis Treatment Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Kidney Fibrosis Treatment Market Company Profiles

36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Kidney Fibrosis Treatment Market Other Major And Innovative Companies

Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Chinook Therapeutics Inc., Akebia Therapeutics Inc., Travere Therapeutics Inc., Reata Pharmaceuticals Inc., ProKidney LLC, Tvardi Therapeutics Inc., Alentis Therapeutics AG, Galecto Biotech AB, Vertex Pharmaceuticals Incorporated, Insilico Medicine Inc., Purespring Therapeutics Inc., La Jolla Pharmaceutical Company, Cara Therapeutics Inc.

38. Global Kidney Fibrosis Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Kidney Fibrosis Treatment Market

40. Kidney Fibrosis Treatment Market High Potential Countries, Segments and Strategies

40.1 Kidney Fibrosis Treatment Market In 2030 - Countries Offering Most New Opportunities

40.2 Kidney Fibrosis Treatment Market In 2030 - Segments Offering Most New Opportunities

40.3 Kidney Fibrosis Treatment Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Kidney Fibrosis Treatment Market, Overview Of Key Products - Product Examples

Table 2: Global Kidney Fibrosis Treatment Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Kidney Fibrosis Treatment Market, Supply Chain Analysis

Table 4: Global Kidney Fibrosis Treatment Market, Major Raw Material Providers

Table 5: Global Kidney Fibrosis Treatment Market, Major Resource Providers

Table 6: Global Kidney Fibrosis Treatment Market, Major Manufacturers (Suppliers)

Table 7: Global Kidney Fibrosis Treatment Market, Major Distributors And Channel Partners

Table 8: Global Kidney Fibrosis Treatment Market, Key Technologies & Future Trends

Table 9: Global Kidney Fibrosis Treatment Market, Major Trends

Table 10: Global Kidney Fibrosis Treatment Market, Major End Users

Table 11: Global Kidney Fibrosis Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Kidney Fibrosis Treatment Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Kidney Fibrosis Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Kidney Fibrosis Treatment Market - TAM, US$ Billion, 2025

Table 15: Global Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Kidney Fibrosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Angiotensin-Converting Enzyme (Ace) Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Angiotensin Ii Receptor Blockers (Arbs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Pirfenidone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Renin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Vasopeptidase Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Kidney Fibrosis Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Global Kidney Fibrosis Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Asia-Pacific, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: China, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: India, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Japan, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Australia, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Indonesia, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South Korea, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Taiwan, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: South East Asia, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Western Europe, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: UK, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Germany, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: France, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Italy, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Spain, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Eastern Europe, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Russia, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: North America, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: USA, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Canada, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: South America, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Brazil, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Middle East, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Africa, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 99: Global Kidney Fibrosis Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 100: Global Kidney Fibrosis Treatment Market - Company Scoring Matrix

Table 101: F. Hoffmann-La Roche Ltd. Financial Performance

Table 102: Merck & Co. Inc. Financial Performance

Table 103: Bayer AG Financial Performance

Table 104: AstraZeneca PLC Financial Performance

Table 105: Gilead Sciences Inc. Financial Performance

Table 106: Global Kidney Fibrosis Treatment Market, Competitive Benchmarking (In USD Billions)

Table 107: Global Kidney Fibrosis Treatment Market, Competitive Dashboard

Table 108: Global Kidney Fibrosis Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 109: Global, Kidney Fibrosis Treatment Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Table 110: Global, Kidney Fibrosis Treatment Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Table 111: Global, Kidney Fibrosis Treatment Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Kidney Fibrosis Treatment Market, Overview Of Key Products - Product Examples

Figure 2: Global Kidney Fibrosis Treatment Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Kidney Fibrosis Treatment Market, Supply Chain Analysis

Figure 4: Global Kidney Fibrosis Treatment Market, Major Raw Material Providers

Figure 5: Global Kidney Fibrosis Treatment Market, Major Resource Providers

Figure 6: Global Kidney Fibrosis Treatment Market, Major Manufacturers (Suppliers)

Figure 7: Global Kidney Fibrosis Treatment Market, Major Distributors And Channel Partners

Figure 8: Global Kidney Fibrosis Treatment Market, Key Technologies & Future Trends

Figure 9: Global Kidney Fibrosis Treatment Market, Major Trends

Figure 10: Global Kidney Fibrosis Treatment Market, Major End Users

Figure 11: Global Kidney Fibrosis Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Kidney Fibrosis Treatment Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Kidney Fibrosis Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Kidney Fibrosis Treatment Market - TAM, US$ Billion, 2025

Figure 15: Global Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Kidney Fibrosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Angiotensin-Converting Enzyme (Ace) Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Angiotensin Ii Receptor Blockers (Arbs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Pirfenidone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Renin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Vasopeptidase Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Kidney Fibrosis Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Global Kidney Fibrosis Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Asia-Pacific, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: China, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: India, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Japan, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Australia, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Indonesia, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South Korea, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Taiwan, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: South East Asia, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Western Europe, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: UK, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Germany, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: France, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Italy, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Spain, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Eastern Europe, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Russia, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: North America, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: USA, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Canada, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: South America, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Brazil, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Middle East, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Africa, Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 99: Global Kidney Fibrosis Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 100: Global Kidney Fibrosis Treatment Market - Company Scoring Matrix

Figure 101: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 102: Merck & Co. Inc. Financial Performance

Figure 103: Bayer AG Financial Performance

Figure 104: AstraZeneca PLC Financial Performance

Figure 105: Gilead Sciences Inc. Financial Performance

Figure 106: Global Kidney Fibrosis Treatment Market, Competitive Benchmarking (In USD Billions)

Figure 107: Global Kidney Fibrosis Treatment Market, Competitive Dashboard

Figure 108: Global Kidney Fibrosis Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 109: Global, Kidney Fibrosis Treatment Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Figure 110: Global, Kidney Fibrosis Treatment Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Figure 111: Global, Kidney Fibrosis Treatment Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Late Stage Chronic Kidney Disease Drugs Market Report 2026 - Global Outlook – By Product Type (Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders), By Indication Type (Late Stage Chroni...

Kidney Disease Market Report 2026 - Global Outlook – By Treatment (Medication, Dialysis, Surgery, Other Treatments), By Indication (Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indications)...

Continuous Renal Replacement Therapy Market Report 2026 - Global Outlook – By Product (System, Consumables), By Therapy (Renal, Non-Renal), By Modality (Slow Continuous Ultra-Filtration (SCUF), Continuous Venovenous Hemo...

Uterine Fibroids Treatment Market Report 2026 - Global Outlook – By Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids, Pedunculated Fibroids), By Treatment Type (Hormone Therapy, Androgens, Gonadotropin...

Fibromyalgia Treatment Market Report 2026 - Global Outlook – By Type (Symptomatic Treatment, Targeted Treatment), By Drug Class (Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Other Drugs), By Distributio...

Diabetic Kidney Disease Market Report 2026 - Global Outlook – By Type (Type 1 Diabetes, Type 2 Diabetes), By Treatment (Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant In...

Kidney Biopsy Market Report 2026 - Global Outlook – By Type (Percutaneous Biopsy, Surgical Biopsy), By Indication (Kidney Failure, Kidney Transplant, Hematuria, Proteinuria), By End-User (Hospitals And Clinics, Tertiary ...

Frequently Asked Questions

How big is the Kidney Fibrosis Treatment Market?

The Kidney Fibrosis Treatment market was valued at $6.06 billion in 2025, increased to $6.54 billion in 2026, and is projected to reach $8.84 billion by 2030.

What is the Kidney Fibrosis Treatment market growth?

The global Kidney Fibrosis Treatment market is expected to grow at a CAGR of 7.8% from 2026 to 2035 to reach $8.84 billion by 2035.

Who are the key players in Kidney Fibrosis Treatment market?

Some Key Players in the Kidney Fibrosis Treatment market Include, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, AstraZeneca PLC, Gilead Sciences Inc., Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Chinook Therapeutics Inc., Akebia Therapeutics Inc., Travere Therapeutics Inc., Reata Pharmaceuticals Inc., ProKidney LLC, Tvardi Therapeutics Inc., Alentis Therapeutics AG, Galecto Biotech AB, Vertex Pharmaceuticals Incorporated, Insilico Medicine Inc., Purespring Therapeutics Inc., La Jolla Pharmaceutical Company, Cara Therapeutics Inc .

What is the anticipated growth trend for the Kidney Fibrosis Treatment market?

Major trend in this market includes: Targeted Ileal-Release Immunomodulatory Therapies Drive Treatment Advancements . For further insights on this market. request a sample here

Which region has the most growth potential in the Kidney Fibrosis Treatment market?

North America was the largest region in the kidney fibrosis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney fibrosis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.